Quick Takeaways
- Rosalind Advisors, Inc. filed SCHEDULE 13G/A for Cellectar Biosciences, Inc. Common Shares (CLRB).
- Disclosed ownership: 5.5%.
- Date of event: 31 Dec 2025.
Rosalind Advisors, Inc. - 31 Dec 2025 SCHEDULE 13G/A Report for Cellectar Biosciences, Inc. Common Shares (CLRB)
- Filing Manager
- Rosalind Advisors, Inc.
- Reporting Manager
- Rosalind Advisors, Inc.
- Symbol
- CLRB
- Shares outstanding
- 4,503,909 shares
- Disclosed Ownership
- 247,715 shares
- Ownership
- 5.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 10 Feb 2026, 15:23:12 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 03 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Rosalind Advisors, Inc. disclosed 5.5% ownership in Cellectar Biosciences, Inc. Common Shares (CLRB) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 03 Feb 2025.
- Current filing was accepted on 10 Feb 2026, 15:23.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 5.5% | 247,715 | 0 | 247,715 | Steven Salamon | President | |
| SALAMON STEVEN A J | 5.5% | 247,715 | 0 | 247,715 | Steven Salamon | Steven Salamon | |
| Aharon Gil | 5.5% | 247,715 | 130 | 247,715 | Gil Aharon | Gil Aharon | |
| Rosalind Master Fund L.P. | 4.1% | 185,036 | 0 | 185,036 | Mike McDonald | Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund) | |
| Rosalind Opportunities Fund I L.P. | 1.4% | 62,678 | 0 | 62,678 | Steven Salamon | Director, Rosalind Opportunities Fund I GP. Inc. (as General Partners to Rosalind Opportunities Fund I) |